BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 1786633)

  • 1. Biology of tumors of the peripheral nervous system.
    Brodeur GM; Moley JF
    Cancer Metastasis Rev; 1991 Dec; 10(4):321-33. PubMed ID: 1786633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroblastoma--clinical applications of molecular parameters.
    Brodeur GM
    Brain Pathol; 1990 Sep; 1(1):47-54. PubMed ID: 1669693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroblastoma: clinical significance of genetic abnormalities.
    Brodeur GM
    Cancer Surv; 1990; 9(4):673-88. PubMed ID: 2101728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p.
    Benn DE; Dwight T; Richardson AL; Delbridge L; Bambach CP; Stowasser M; Gordon RD; Marsh DJ; Robinson BG
    Cancer Res; 2000 Dec; 60(24):7048-51. PubMed ID: 11156410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in Genomic Profiles and Outcomes Between Thoracic and Adrenal Neuroblastoma.
    Oldridge DA; Truong B; Russ D; DuBois SG; Vaksman Z; Mosse YP; Diskin SJ; Maris JM; Matthay KK
    J Natl Cancer Inst; 2019 Nov; 111(11):1192-1201. PubMed ID: 30793172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of chromosome 1p loss of heterozygosity in neuroblastoma.
    Maris JM; White PS; Beltinger CP; Sulman EP; Castleberry RP; Shuster JJ; Look AT; Brodeur GM
    Cancer Res; 1995 Oct; 55(20):4664-9. PubMed ID: 7553646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes.
    Moley JF; Brother MB; Fong CT; White PS; Baylin SB; Nelkin B; Wells SA; Brodeur GM
    Cancer Res; 1992 Feb; 52(4):770-4. PubMed ID: 1346584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression profile of alternatively spliced neuronal c-src RNA distinguishes between human tumours of the sympatho-adrenal lineage.
    Ortoft E; Bjelfman C; Hedborg F; Grimelius L; Påhlman S
    Int J Cancer; 1995 Jan; 60(1):38-44. PubMed ID: 7529211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathology of human neuroblastomas.
    Brodeur GM
    Semin Diagn Pathol; 1994 May; 11(2):118-25. PubMed ID: 7809505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas.
    Bender BU; Gutsche M; Gläsker S; Müller B; Kirste G; Eng C; Neumann HP
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4568-74. PubMed ID: 11134110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic analysis in the examination of solid tumors in children.
    Mertens F; Mandahl N; Mitelman F; Heim S
    Pediatr Hematol Oncol; 1994; 11(4):361-77. PubMed ID: 7947009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct cytogenetic pathways of advanced-stage neuroblastoma tumors, detected by spectral karyotyping.
    Stark B; Jeison M; Bar-Am I; Glaser-Gabay L; Mardoukh J; Luria D; Feinmesser M; Goshen Y; Stein J; Abramov A; Zaizov R; Yaniv I
    Genes Chromosomes Cancer; 2002 Jul; 34(3):313-24. PubMed ID: 12007192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma.
    Caron H; van Sluis P; de Kraker J; Bökkerink J; Egeler M; Laureys G; Slater R; Westerveld A; Voûte PA; Versteeg R
    N Engl J Med; 1996 Jan; 334(4):225-30. PubMed ID: 8531999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity for alleles on chromosomes 11q and 14q in neuroblastoma.
    Srivatsan ES; Murali V; Seeger RC
    Prog Clin Biol Res; 1991; 366():91-8. PubMed ID: 2068183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic parameters of neuroblastomas.
    Westermann F; Schwab M
    Cancer Lett; 2002 Oct; 184(2):127-47. PubMed ID: 12127685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low frequency of ras gene mutations in neuroblastomas, pheochromocytomas, and medullary thyroid cancers.
    Moley JF; Brother MB; Wells SA; Spengler BA; Biedler JL; Brodeur GM
    Cancer Res; 1991 Mar; 51(6):1596-9. PubMed ID: 1998949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial risk for neuroendocrine tumors.
    Anderson RJ; Lynch HT
    Curr Opin Oncol; 1993 Jan; 5(1):75-84. PubMed ID: 8094015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biology of pediatric peripheral neuroectodermal tumors.
    Thiele CJ
    Cancer Metastasis Rev; 1991 Dec; 10(4):311-9. PubMed ID: 1786632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intragenic allelic loss and promoter hypermethylation of the RIZ1 tumor suppressor gene in parathyroid tumors and pheochromocytomas.
    Carling T; Du Y; Fang W; Correa P; Huang S
    Surgery; 2003 Dec; 134(6):932-9; discussion 939-40. PubMed ID: 14668725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma.
    Gehring M; Berthold F; Edler L; Schwab M; Amler LC
    Cancer Res; 1995 Nov; 55(22):5366-9. PubMed ID: 7585602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.